Literature DB >> 27528270

Ultrafiltration Rate Clinical Performance Measures: Ready for Primetime?

Jennifer E Flythe1,2.   

Abstract

Mounting evidence supports a strong association between fluid management and outcomes among individuals receiving maintenance hemodialysis. The speed of fluid removal during dialysis (ultrafiltration, UF) is a modifiable aspect of fluid management that has attracted recent attention as a potential performance measure for facility fluid management practices. Observational data support an association between higher UF rates and adverse outcomes. This association is supported by the plausible pathophysiologic rationale of hypoperfusion-induced ischemic injury to the heart and other end-organs. However, no published clinical trial has studied the impact of lowering UF rates on clinical and patient-centered outcomes. Lowering UF rates requires interdialytic weigh gain reduction and/or extension of dialysis time. Weight gain reduction has proven difficult despite nutritional programs focused on salt and fluid restrictions, and patients are generally averse to longer treatment times. Thus, imposition of UF rate limitations may lead to failed target weight achievement and volume expansion over time. Despite these potential unintended consequences, the National Quality Forum endorsed an UF rate clinical performance measure in 2015. Prior to implementation of quality measure-imposed UF rate limitations, prospective studies of UF rates and outcomes are needed.
© 2016 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2016        PMID: 27528270     DOI: 10.1111/sdi.12529

Source DB:  PubMed          Journal:  Semin Dial        ISSN: 0894-0959            Impact factor:   3.455


  7 in total

Review 1.  Volume Balance and Intradialytic Ultrafiltration Rate in the Hemodialysis Patient.

Authors:  Jason A Chou; Kamyar Kalantar-Zadeh
Journal:  Curr Heart Fail Rep       Date:  2017-10

2.  No Survival Benefit in Octogenarians and Nonagenarians with Extended Hemodialysis Treatment Time.

Authors:  Gang Jee Ko; Yoshitsugu Obi; Melissa Soohoo; Tae Ik Chang; Soo Jeong Choi; Csaba P Kovesdy; Elani Streja; Connie M Rhee; Kamyar Kalantar-Zadeh
Journal:  Am J Nephrol       Date:  2018-11-13       Impact factor: 3.754

3.  Ultrafiltration Rate, Residual Kidney Function, and Survival Among Patients Treated With Reduced-Frequency Hemodialysis.

Authors:  Yu-Ji Lee; Yusuke Okuda; John Sy; Yong Kyu Lee; Yoshitsugu Obi; Seong Cho; Joline L T Chen; Anna Jin; Connie M Rhee; Kamyar Kalantar-Zadeh; Elani Streja
Journal:  Am J Kidney Dis       Date:  2019-12-06       Impact factor: 8.860

4.  High Ultrafiltration Rates and Mortality in Hemodialysis Patients: Current Evidence and Future Steps.

Authors:  Katherine Scovner Ravi
Journal:  Kidney360       Date:  2022-08-25

Review 5.  Mechanisms, Clinical Implications, and Treatment of Intradialytic Hypotension.

Authors:  Patrick B Reeves; Finnian R Mc Causland
Journal:  Clin J Am Soc Nephrol       Date:  2018-02-26       Impact factor: 8.237

6.  Thinking Volume First: Developing a Multifaceted Systematic Approach to Volume Management in Hemodialysis.

Authors:  Daniel Blum; William Beaubien-Souligny; Samuel A Silver; Ron Wald
Journal:  Can J Kidney Health Dis       Date:  2019-09-26

7.  Cost-effectiveness and value of information analysis of multiple frequency bioimpedance devices for fluid management in people with chronic kidney disease having dialysis.

Authors:  Elisabet Jacobsen; Moira Cruickshank; David Cooper; Angharad Marks; Miriam Brazzelli; Graham Scotland
Journal:  Cost Eff Resour Alloc       Date:  2021-04-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.